89 related articles for article (PubMed ID: 16493588)
1. Negligible contribution of molecular mobility to the degradation rate of insulin lyophilized with poly(vinylpyrrolidone).
Yoshioka S; Aso Y; Miyazaki T
J Pharm Sci; 2006 Apr; 95(4):939-43. PubMed ID: 16493588
[TBL] [Abstract][Full Text] [Related]
2. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
Yoshioka S; Aso Y
Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
[TBL] [Abstract][Full Text] [Related]
3. Degradation rate of lyophilized insulin, exhibiting an apparent Arrhenius behavior around glass transition temperature regardless of significant contribution of molecular mobility.
Yoshioka S; Miyazaki T; Aso Y
J Pharm Sci; 2006 Dec; 95(12):2684-91. PubMed ID: 16892208
[TBL] [Abstract][Full Text] [Related]
4. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.
Yoshioka S; Miyazaki T; Aso Y
Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386
[TBL] [Abstract][Full Text] [Related]
5. Temperature- and glass transition temperature-dependence of bimolecular reaction rates in lyophilized formulations described by the Adam-Gibbs-Vogel equation.
Yoshioka S; Aso Y; Kojima S
J Pharm Sci; 2004 Apr; 93(4):1062-9. PubMed ID: 14999742
[TBL] [Abstract][Full Text] [Related]
6. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
7. Molecular mobility of lyophilized poly(vinylpyrrolidone) and methylcellulose as determined by the laboratory and rotating frame spin-lattice relaxation times of 1H and 13C.
Yoshioka S; Aso Y; Kojima S
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1289-92. PubMed ID: 14600374
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
9. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.
Yoshioka S; Miyazaki T; Aso Y; Kawanishi T
Pharm Res; 2007 Sep; 24(9):1660-7. PubMed ID: 17404806
[TBL] [Abstract][Full Text] [Related]
10. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.
Miyazaki T; Yoshioka S; Aso Y; Kawanishi T
Int J Pharm; 2007 May; 336(1):191-5. PubMed ID: 17184940
[TBL] [Abstract][Full Text] [Related]
11. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 1999 Jan; 16(1):135-40. PubMed ID: 9950292
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
[TBL] [Abstract][Full Text] [Related]
14. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals.
Yoshioka S; Aso Y
J Pharm Sci; 2007 May; 96(5):960-81. PubMed ID: 17455355
[TBL] [Abstract][Full Text] [Related]
15. Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone).
Lai MC; Hageman MJ; Schowen RL; Borchardt RT; Laird BB; Topp EM
J Pharm Sci; 1999 Oct; 88(10):1081-9. PubMed ID: 10514359
[TBL] [Abstract][Full Text] [Related]
16. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by (13)C-NMR relaxation time.
Aso Y; Yoshioka S; Zhang J; Zografi G
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):822-6. PubMed ID: 12045339
[TBL] [Abstract][Full Text] [Related]
17. Sudden rise of crystal growth rate of nifedipine near T(g) without and with polyvinylpyrrolidone.
Ishida H; Wu T; Yu L
J Pharm Sci; 2007 May; 96(5):1131-8. PubMed ID: 17455342
[TBL] [Abstract][Full Text] [Related]
18. Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP.
Caron V; Bhugra C; Pikal MJ
J Pharm Sci; 2010 Sep; 99(9):3887-900. PubMed ID: 20575050
[TBL] [Abstract][Full Text] [Related]
19. Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: stabilization against covalent dimer formation.
Strickley RG; Anderson BD
J Pharm Sci; 1997 Jun; 86(6):645-53. PubMed ID: 9188045
[TBL] [Abstract][Full Text] [Related]
20. Temperature dependence of bimolecular reactions associated with molecular mobility in lyophilized formulations.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 2000 Aug; 17(8):925-9. PubMed ID: 11028936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
